Adult bacterial meningitis: Aetiology, penicillin susceptibility, risk factors, prognostic factors and guidelines for empirical antibiotic treatment

Clinical Microbiology and Infection

Volumn 10, Issue 8, 2004, Pages 709-717

  Meyer, C N ^a   Samuelsson, I S ^b   Galle, M ^b   Bangsborg, J M ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Adult bacterial meningitis; Antibiotic treatment; Meningitis; Penicillin susceptibility

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; PENICILLIN G;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL MENINGITIS; CAPNOCYTOPHAGA; COMMUNICABLE DISEASE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; CONVULSION; DENMARK; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HEMOLYTIC STREPTOCOCCUS; HOSPITAL CARE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; KLEBSIELLA; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEUS VULGARIS; PSEUDOMONAS; RISK FACTOR; SALMONELLA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; PSEUDOMONAS;

EID: 4544269992     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00925.x     Document Type: Article

References (23)

1. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129: 862-869.
2. Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S. Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med 1997; 157: 425-430.
3. Schmutzhard E, Williams KJ, Vukmirovits G, Chmelik V, Pfausler B, Featherstone A. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. J Antimicrob Chemother 1995; 36(suppl A): 85-97.
4. Hussein AS, Shafran SD. Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore) 2000; 79: 360-368.
5. Kyaw MH, Bramley JC, Clark S, Christie P, Jones IG, Campbell H. Prevalence of moderate penicillin resistant invasive Neisseria meningitidis infection in Scotland, 1994-9. Epidemiol Infect 2002; 128: 149-156.
6. Hasbun R, Aronin SI, Quagliarello VJ. Treatment of bacterial meningitis. Comp Ther 1999; 25: 73-81.
7. van De Beek D, de Gans J, Spanjaard L, Vermeulen M, Dankert J. Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother 2002; 49: 661-666.
8. Begg N, Cartwright KA, Cohen J et al. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect 1999; 39: 1-15.
9. Roord JJ, Kaandorp CJ. CBO-guideline 'Bacterial meningitis'. Ned Tijdschr Geneeskd 2001; 145: 211-214.
10. Justesen T, Korsager B, Kolmos HJ, Gerstoft J. Recommendations in the use of antibiotics. In: Aldershvile J, Hansen MS, Kampmann JP, Vej-Hansen B, eds. The drug index 2001/2002. Copenhagen: The Danish Medical Association, 2002; 831-855.
11. Eriksen NH, Scheibel J, Vejlsgaard R. Purulent meningitis in Denmark. Nord Med 1990; 105: 252-254.
12. Meyer CN. Empirical antibiotic therapy for purulent meningitis in Danish adults. Ugeskr Laeger 2003; 165: 34-37.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
14. Pedersen G, Schonheyder HC, Steffensen FH, Sorensen HT. Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemia. J Antimicrob Chemother 1999; 43: 119-126.
15. Goldacre MJ, Miller DL. Completeness of statutory notification for acute bacterial meningitis. BMJ 1976; 2: 501-503.
16. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990; 162: 1316-1323.
17. Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N. Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases. Arch Intern Med 1993; 153: 1902-1908.
18. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 1992; 11: 694-698.
19. Johnson JR. Delayed treatment of bacterial meningitis. Ann Intern Med 1999; 131: 715.
20. Miner JR, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med 2001; 21: 387-392.
21. Miller LG, Choi C. Meningitis in older patients: how to diagnose and treat a deadly infection. Geriatrics 1997; 52: 43-55.
22. Rasmussen HH, Sorensen HT, Moller-Petersen J, Mortensen FV, Nielsen B. Bacterial meningitis in elderly patients: clinical picture and course. Age Ageing 1992; 21: 216-220.
23. Moller K, Frederiksen EH, Wandall JH, Skinhoj P. Meningitis caused by streptococci other than Streptococcus pneumoniae: a retrospective clinical study. Scand J Infect Dis 1999; 31: 375-381.